Pulmonary adenocarcinoma of low malignant potential defines indolent NSCLC associated with overdiagnosis in the national lung screening trial.
Saved in:
| Title: | Pulmonary adenocarcinoma of low malignant potential defines indolent NSCLC associated with overdiagnosis in the national lung screening trial. |
|---|---|
| Authors: | Burks EJ; Department of Pathology and Laboratory Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston Medical Center, Boston, MA, USA.; Department of Translational Research, Ian C. Summerhayes Cell and Molecular Biology Laboratory, Lahey Hospital and Medical Center, Burlington, MA, USA., Sullivan TB; Department of Translational Research, Ian C. Summerhayes Cell and Molecular Biology Laboratory, Lahey Hospital and Medical Center, Burlington, MA, USA., Rieger-Christ KM; Department of Translational Research, Ian C. Summerhayes Cell and Molecular Biology Laboratory, Lahey Hospital and Medical Center, Burlington, MA, USA. |
| Source: | Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2025 Jan; Vol. 42 (1), pp. CBM230452. Date of Electronic Publication: 2024 May 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Publications Country of Publication: United States NLM ID: 101256509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-8592 (Electronic) Linking ISSN: 15740153 NLM ISO Abbreviation: Cancer Biomark Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1875-8592 |
|---|---|
| DOI: | 10.3233/CBM-230452 |
